Doxorubicin is widely applied in hematological and solid tumor treatment but limited by its off-
target cardiotoxicity. us, cardioprotective potential and mechanism (s) of CVE in DOX …

Doxorubicin is widely applied in hematological and solid tumor treatment but limited by its off‐
target cardiotoxicity. Thus, cardioprotective potential and mechanism (s) of CVE in DOX …

Doxorubicin has cardiotoxic effects that limit its clinical benefit in cancer patients. This study
aims to investigate the protective effects of the total flavonoids from Clinopodium chinense …

Background and Purpose: Hepatorenal toxicity is a side effect of the anthracycline cytotoxic
antibiotics, doxorubicin that is used in cancer treatment. The study investigated the …

Background Doxorubicin (DOX) is a broad-spectrum anti-tumor drug that has been
associated with cardiotoxicity. Plant extracts have been shown to confer protection against …

Background As an anthracycline antibiotic, doxorubicin (DOX) is one of the most potent and
widely used chemotherapeutic agents for various types of solid tumors. Unfortunately …

Doxorubicin (DOX) has been extensively utilized in cancer treatment. However, DOX
administration has adverse effects, such as cardiac injury. This study intends to analyze the …

Cardiotoxicity is a major limiting factor for clinical use of doxorubicin (DOX) in chemotherapy.
This study aimed to evaluateeffectiveness of radish root extract (30mg/kg BW) to attenuate …

Background Cardiotoxicity and related complications are well-known adverse effects of
anticancer drugs like doxorubicin (DOX). A medicinal plant called Rhododendron arboreum …

Objective Our study aimed to investigate the possible protective effects of quercetin (QCT)
on doxorubicin (DOX)-induced cardiotoxicity in rats. Background DOX is an antineoplastic …